Background and Objectives: Efflux-based systems may play a role in resistance to fluoroquinolones in Gram-negative pathogenic bacteria. Extracts of some medicinal plants contain molecules that can act as efflux pumps inhibitors. In this study, we aimed to evaluate antibacterial activities of ethanolic and chloroform extracts of Cinnamomum zeylanicum and their possible synergistic activity with ciprofloxacin against some Gram-negative pathogenic bacteria. We also analyzed the extracts for presence of efflux pump inhibitors against the examined bacteria.
extracts. The evaporated extracts were kept in a refrigerator for future use (10). Reference strains of P. aeroginosa ATCC 9027, Acinetobacter baumannii, NCTC 13305, Escherichia coli ATCC 25922 and Salmonella enteritidis RTCC 2465 were used for assays. The strains were first grown in Lauria Bertani broth (Biomark, India) in a refrigerator and then sub-cultured on suitable media 24 hours prior to antimicrobial testing. In all antibacterial tests, Mueller Hinton broth (Merck, Germany), ciprofloxacin (SigmaAldrich) and PAβN (Sigma-Aldrich) were used as medium, microbial growth indicator and an EPI, respectively. Minimum inhibitory concentrations (MICs) of the extracts and ciprofloxacin were determined via tube dilution test. MICs of drug combinations were determined by double serial microdilution method according to the Clinical and Laboratory Standards Institute guidelines (11). In brief, the examined bacteria were grown at 37 o C for 18-24 hours. Culture turbidity was adjusted to 0.5 McFarland (1.5×10 8 CFU/ml) and the cultures were diluted to obtain an inoculum of 5×10 5 CFU/well. Four MIC of drug/drugs were inoculated into the first wells of 96-well microplates, followed by double dilution in subsequent wells. The two last wells were used for the positive and negative controls. The well-plates were placed on a shaking incubator for 18 hours at 37 o C. Lowest concentration that inhibited the growth of bacteria was defined as the MIC. To evaluate synergistic activity of ciprofloxacin with the ethanolic and chloroform extracts, antibacterial activity of ciprofloxacin-extract combinations was compared with that of ciprofloxacin-PAßN (30 µg/ml). Synergistic activity of drug combinations was calculated as the MIC Antibiotic combination /MIC Antibiotic alone ratio and the results were interpreted as follows: synergy (< 0.5), indifferent (0.5 to 4) and antagonism (> 4) (12, 13) . All assays were performed in duplicate. Effect of drug combinations on efflux pumps in synergistic cases was interpreted according to a method described by Martins et al. (14) with slight modifications. Briefly, the examined strains were cultured on Mueller Hinton agar (MHA, Merck, Germany). After creating four wells in the medium, 50 µl ethidium bromide (EB, 6 µg/mL) and 50 µl distilled water were inoculated into one well.
INTRODUCTION
Since bacterial efflux pumps can decrease antibiotics concentration inside bacterial cells and thereby increase resistance to antimicrobials, recent studies have taken an interest in discovering safe inhibitors of these pumps. Multidrug resistant Gram-negative bacteria utilize multiple mechanisms including reduced outer membrane permeability and active efflux against numerous antimicrobials (1) . Recent studies show that efflux-based systems may play a role in resistance of Gram-negative pathogens to fluoroquinolones (2) . Overexpression of these pumps in pathogenic bacteria results in the emergence of ciprofloxacin resistance (2, 3). Phenylalanine-arginine β-naphthylamide (PAßN) is a known efflux pump inhibitor (EPI) (4) that selectively inhibits the activity of a broad range of efflux pumps such as MexAB-OprM, MexEF-OprN, MexCD-OprJ and MexXY-OprM in Pseudomonas aeruginosa and AcrAB-TolC in some Enterobacteriaceae species (5). Many medicinal plants have been traditionally used in various parts of the world including Iran for the treatment of infections caused by pathogenic bacteria (6, 7). It is reported that extracts of some medicinal plants contain molecules that can act as EPIs for bacteria (8). Cinnamomum zeylanicum is a well-known medicinal herb that is commonly used in foods for its medicinal properties (9) . In this study, we examine the antibacterial activity of ethanolic and chloroform extracts of C. zeylanicum combined with ciprofloxacin against some Gram-negative pathogenic bacteria. We also analyzed the extracts for presence of EPI for the examined bacteria.
MATERIALS AND METHODS
Dried leaves and branches of C. zeylanicum were obtained from local markets of Shahrekord, Iran. After grinding, the plant extracts were prepared through maceration. Briefly, powdered plants in conical flasks were mixed with ethanol (85%) and chloroform at room temperature for 2-3 days. Daily filtration and addition of fresh solvents were done for ethanol extraction, while one-stage filtration was carried out for chloroform extraction. The obtained filtrates were evaporated by incubation at 34 °C for the ethanol and under biolaminar safety hood for the chloroform 7/ Ebrahimi and colleagues investigating the MICs, the ethanolic extract of C. zeylanicum showed synergistic activity with ciprofloxacin against S. enteritidis and E. coli, while for the chloroform extract, a synergistic activity was observed against A. bumannii and S. enteritidis (Table 1) . Increased amount of EB accumulation in the presence of an EPI, such as PAβN indicates efflux inhibition (12) . To clarify whether the synergistic activity with ciprofloxacin exhibited by the extracts of C. zeylanicum was due to efflux inhibition, the accumulation of EB in bacterial cells in the presence and absence of 1 MIC of each extract was evaluated. In all examined synergistic cases, the extracts of C. zeylanicum increased the amount of EB accumulation (i.e. reduced efflux). In the case of P. aeruginosa and A. baumanni, the ethanolic extract reduced the MIC of ciprofloxacin but PAβN did not (Table 1) . the chloroform extract. These results confirm that the extracts of C. zeylanicum contain compounds with efflux pump inhibitory activity. There are many bacterial efflux pumps that expel ciprofloxacin out of the cell, and several studies have shown that plant extracts could act as EPI against these pumps (1, 8) . In all examined synergistic cases, the extracts of C. zeylanicum increased the amount of EB accumulation (i.e. reduced efflux). Evidence suggests that extract of other plants may also c ontain compounds with efflux pump inhibitory or antibacterial activities (16, 18) . A study reported that essential oil from a Corsican plant, Helichrysum italicum, could reduce the MIC of chloramphenicol against Enterobacter aerogenes, A. baumannii and P. aeruginosa (16) . The ethanolic extract combined with Synergistic ethanolic or chloroform extracts along with EB were inoculated into two other wells, and PaβN+EB (1 MIC concentration and 50 µL volume for each case) was inoculated in the last well. After overnight incubation at 37 o C, accumulation of EB in the presence of an EPI such as PAβN indicated efflux inhibition (detected by fluorescence from the excitation of EB by UV light) (14) .
RESULTS
The chloroform and ethanolic extracts of C. zeylanicum in combination with ciprofloxacin were examined for possible synergistic and EPI activities. The MICs of the ethanolic and chloroform extracts and drug combinations against the examined bacteria are presented in table 1. The chloroform extract showed the best antibacterial activity against the examined bacterial strains. When
DISCUSSION
Nowadays, it is crucial to discover novel approaches and antimicrobials to combat antibiotic resistance and treat resistant bacterial infections. In this regard, identification of natural compounds with efflux pump inhibitory properties is considered a promising approach (15, 18) . In the present study, we examined the antibacterial and efflux pump inhibitory activities of C. zeylanicum extracts. It is reported that the bacterial strains examined in our study contain multidrug resistance efflux pumps (2, 5) . It appears that the extracts of C. zeylanicum inhibited the growth of all tested bacterial strains within a concentration range of 3120 to 100000 μg/mL. The best antibiotic-potentiation activity with ciprofloxacin was observed against S. enteritidis and E. coli by the ethanolic extract and against S. enteritidis and A. baumanni by 
CONCLUSION
Combination of the extracts of C. zeylanicum and ciprofloxacin could be effective for treatment of infections caused by the tested bacterial strains.
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There is no conflict of interest regarding the publication of this article. ciprofloxacin showed significantly greater antibiotic activity against S. enteritidis, P. aeroginosa and A. baumannii compared with the PaβN-ciprofloxacin combination (Table 1) . This shows that at least one active compound from this plant, acting inside the bacterial cell could be the powerful substrate of efflux pumps of the mentioned bacteria. Other studies demonstrated the synergistic effects of C. zeylanicum extracts with different antibiotics on other bacteria, thus suggesting that some constituents of these extracts can act as an EPI (18). The MIC of ciprofloxacin against P. aeroginosa and A. baumannii decreased when used in combination with the extracts but not with PAβN. This indicates that these extracts may also act by damaging cell membrane or cell wall of the bacteria and thereby facilitate the penetration of ciprofloxacin into bacterial cell (19, 20) . The presence of AcrB efflux pumps confers PAβN resistance (21), which may indicate that the strains of P. aeroginosa and A. baumannii tested in our study overexpress AcrB efflux pumps. However, it is suggested to further investigate active constituents and phytochemica propertie of C. zeylanicum extracts for elucidating the
